What are the likely causes of hematuria in a patient who has just completed a course of ceftriaxone, and what diagnostic work‑up should be performed?

Hematuria After Ceftriaxone: Likely Causes and Diagnostic Approach

In a patient who has just completed ceftriaxone and now presents with hematuria, the most critical concern is ceftriaxone-induced immune hemolytic anemia, which requires immediate discontinuation of the drug and urgent evaluation for hemolysis.

Likely Causes in This Clinical Context

1. Drug-Induced Immune Hemolytic Anemia (Most Serious)

Ceftriaxone is one of the most common antibiotics causing drug-induced immune hemolytic anemia (DIIHA), which can present with hemoglobinuria (blood in urine from hemolyzed red blood cells) 1. This is a medical emergency that can lead to:

• Severe anemia
• Organ failure
• Death if not recognized promptly 2, 3

Key distinguishing features:

• Wine-colored or dark urine (hemoglobinuria, not true hematuria)
• Rapid onset during or shortly after ceftriaxone therapy
• Associated symptoms: pallor, jaundice, fatigue, back pain, abdominal pain
• May include systemic symptoms: rash, itching, breathing difficulty 2

2. Ceftriaxone-Related Urolithiasis

Ceftriaxone-calcium precipitates can form in the urinary tract, causing:

• Urolithiasis with true hematuria
• Ureteral obstruction
• Post-renal acute renal failure 1

Key features:

• More common in pediatric patients
• May be asymptomatic or present with flank pain
• Detectable on ultrasound as sonographic abnormalities
• Reversible upon drug discontinuation 1

3. Underlying Urinary Tract Infection

If ceftriaxone was prescribed for a UTI, the hematuria may represent:

• Persistent or inadequately treated infection
• Complicated UTI with pyelonephritis 4

4. Unrelated Urologic Pathology

The timing may be coincidental, requiring evaluation for:

• Urolithiasis (non-drug related)
• Malignancy (especially if patient >35 years, smoker, or other risk factors)
• Glomerulonephritis
• Trauma 4

Immediate Diagnostic Work-Up

Step 1: Distinguish True Hematuria from Hemoglobinuria (URGENT)

Obtain immediately:

• Complete blood count with differential - look for acute anemia, decreased hemoglobin
• Reticulocyte count - elevated in hemolysis
• Urinalysis with microscopy - hemoglobinuria shows positive dipstick but few/no RBCs on microscopy; true hematuria shows RBCs
• Lactate dehydrogenase (LDH) - markedly elevated in hemolysis
• Indirect bilirubin - elevated in hemolysis
• Haptoglobin - decreased in hemolysis
• Direct antiglobulin test (Coombs test) - positive in immune hemolytic anemia 2, 3

If hemolysis is confirmed:

• STOP ceftriaxone immediately 1
• Initiate supportive care: IV fluids, oxygen, corticosteroids (methylprednisolone)
• Consider transfusion support if severe anemia
• Plasma exchange may be required in severe cases 2
• Consult hematology urgently

Step 2: If True Hematuria (RBCs Present on Microscopy)

Initial laboratory evaluation:

• Urine culture (preferably before any new antibiotics) 4
• Basic metabolic panel - assess renal function
• Serum creatinine and BUN - evaluate for renal impairment
• Assess for proteinuria, RBC casts, dysmorphic RBCs (suggests glomerular disease) 5

Imaging:

• Renal ultrasound - first-line to detect:

  • Ceftriaxone-calcium precipitates in kidneys or bladder
  • Hydronephrosis from ureteral obstruction
  • Stones
  • Masses 1

• CT urography without and with IV contrast - if ultrasound equivocal or high suspicion for:

  • Urolithiasis
  • Malignancy (especially if gross hematuria, age >35, risk factors)
  • Anatomic abnormalities 4

Step 3: Risk Stratification for Malignancy

High-risk features requiring full urologic work-up 4, 6:

• Gross hematuria (30-40% malignancy risk)
• Age ≥60 years
• Male gender
• Smoking history >30 pack-years

• 25 RBCs/HPF

• Occupational chemical exposure
• History of pelvic irradiation
• Chronic UTIs

If high-risk: Cystoscopy is mandatory in addition to imaging 7, 4, 6

Step 4: Specific Considerations

If patient has renal impairment:

• Ceftriaxone dosing may have been inappropriate, increasing risk of neurological complications 1
• Evaluate for adequate hydration 1

If patient had UTI as indication:

• Confirm infection with culture
• Assess treatment adequacy
• Consider alternative pathogens or resistance 8

Critical Pitfalls to Avoid

1. Do not assume hematuria is benign just because patient recently completed antibiotics - hemolytic anemia can be fatal 1, 2

2. Do not restart ceftriaxone if hemolytic anemia is suspected or confirmed - this can trigger severe, potentially fatal hemolysis 2, 3

3. Do not delay imaging in patients with gross hematuria or high-risk features - malignancy must be excluded 4

4. Do not attribute hematuria to anticoagulation alone - full evaluation is still required 4, 9

5. Do not order urine cytology or bladder cancer markers in initial evaluation - these are not recommended and have poor predictive value 6, 9

6. Do not skip cystoscopy in high-risk patients even if imaging is negative - urothelial carcinoma can be missed 7, 6